Europe 13 Demo Day

Micrographia Bio

| Engineering the chemical atlas for modern drug discovery.

Micrographia Bio

Micrographia Bio is a next-generation drug-discovery company, operating at the intersection of ML, Engineering, and Biology. Traditional pharma asks, “Which of these thousands of compounds will cure this target disease?”. We ask, “Which disease is this compound best suited to cure?”

Our technology is 80% ML, 20% cell biology (and 100% “astounding” according to our seven pilot partnerships). Our tech allows us to map each chemical we test to its true activities inside human cells. By aggregating each chemical activity map, we are building an atlas for modern drug discovery.

Meet The Founders


Julia is an Immunologist, Banker, VC and Engineer. From her PhD work at University of Cambridge as a Gates Scholar, she originated and deployed the world’s first $108M Global Health Investment Fund. Most recently, Julia built the UK team for a Boston-based SaaS genomics company.


Christopher is a Molecular Biologist, Machine Learning Engineer, and Roboticist. He completed his PhD and two fellowships at Imperial College London. Most recently, Chris has served as a Machine Learning Engineer for a London start-up, where he helped build autonomous robots for greenhouse harvesting.